Financials
Financial year 2025
Gross margin
€ 6,212
▼ 99% vs 2024
Profit
Healthy€ 31,255
▼ 84% vs 2024
Debts
Low€ 45,687
▼ 91% vs 2024
VIZIPHAR Biosciences from Kasterlee, company number BE0862727797, closed financial year 2025 with a result of € 31,255 after tax. For that financial year VIZIPHAR Biosciences recorded a gross margin of € 6,212 and equity of € 737,214. Compared with financial year 2024, the result moved from € 194,608 to € 31,255. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
What happened at VIZIPHAR Biosciences?
What happened at VIZIPHAR Biosciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 31,255 (▼ 84% vs 2024). Source: NBB ↗
- Gustaaf Van Reet became a director. NBB
- New establishment in Kasterlee. KBO
- Start of the company according to the CBE. KBO
In short
From € 4,856 profit in 2021 to € 31,255 profit in 2025.
Paid € 107,590 in corporate taxes since 2021.
Best year ever: 2024, with € 194,608 profit.
A new publication or filing at VIZIPHAR Biosciences? We notify you, reason included.
Follow VIZIPHAR BiosciencesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind VIZIPHAR Biosciences is Gustaaf Van Reet. Gustaaf Van Reet is also behind VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY, OCTIMET Oncology and DeuterOncology.
Directors
According to the 2025 annual accounts
Gustaaf Van Reet
Director
Also active at: VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY, OCTIMET Oncology, DeuterOncology
since 2023
Establishments
Establishment units
Physical locations of this company
Populierenlaan 14
2460 Kasterlee
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0862.727.797
- VAT number
- BE 0862.727.797
- Registered office
- Populierenlaan 14, 2460 Kasterlee
- Names & denominations
- VIZIPHAR Biosciences
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2004
- Peppol
- Active · Active since 19 Aug 2025